NCT01788592Recruiting
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50000 (estimated)
- First submitted
- 8 Feb 2013
- Start date
- Jan 2003
- Primary completion date
- Oct 2030
- Lead sponsor
- Seung-Jung Park
- Diseases
- Coronary artery disease
- NCT number
- NCT01788592
What you commit to
- Study type: Observational
- Planned participants: 50000
- From Jan 2003 to the primary completion date, Oct 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients with a mixture of several drug eluting stents
Other illness
- terminal illness with life expectancy less than 1 year
Other
- patients with cardiogenic shock
Who the study is looking for
- coronary disease amenable to percutaneous coronary intervention (PCI)
- no clinical and lesion limitations
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Asan Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.